CONSTELLATION PHARMCETICLS I's ticker is CNST and the CUSIP is 210373106. A total of 136 filers reported holding CONSTELLATION PHARMCETICLS I in Q4 2020. The put-call ratio across all filers is 1.58 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $15,484,000 | -6.7% | 458,096 | -35.4% | 0.00% | -25.0% |
| Q1 2021 | $16,591,000 | -20.4% | 709,308 | -2.1% | 0.00% | -20.0% |
| Q4 2020 | $20,856,000 | +178.1% | 724,165 | +95.6% | 0.01% | +150.0% |
| Q3 2020 | $7,500,000 | -23.7% | 370,182 | +13.1% | 0.00% | -33.3% |
| Q2 2020 | $9,835,000 | +242.2% | 327,292 | +258.0% | 0.00% | +200.0% |
| Q1 2020 | $2,874,000 | +357.6% | 91,432 | +585.5% | 0.00% | – |
| Q4 2019 | $628,000 | +197.6% | 13,338 | -59.1% | 0.00% | – |
| Q3 2019 | $211,000 | +44.5% | 32,647 | +202.9% | 0.00% | – |
| Q1 2019 | $146,000 | +41.7% | 10,779 | -29.6% | 0.00% | – |
| Q3 2018 | $103,000 | – | 15,301 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ponoi II Management, LLC | 1,574,229 | $36,821,000 | 28.20% |
| Ponoi Management, LLC | 1,880,623 | $43,988,000 | 25.87% |
| VR Adviser, LLC | 4,016,873 | $93,955,000 | 10.19% |
| Column Group LLC | 2,626,631 | $61,437,000 | 5.89% |
| Euclidean Capital LLC | 554,325 | $12,966,000 | 4.34% |
| GREAT POINT PARTNERS LLC | 872,415 | $20,406,000 | 4.22% |
| Venrock Management V, LLC | 1,570,058 | $36,724,000 | 3.76% |
| COMMODORE CAPITAL LP | 368,448 | $8,618,000 | 3.43% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 621,541 | $14,538,000 | 1.90% |
| Bain Capital Life Sciences Investors, LLC | 1,400,000 | $32,746,000 | 1.86% |